CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13

Cancer Research

Volumn 57, Issue 5, 1997, Pages 846-849

  Gao, Allen Chuan ^a   Lou, Wei ^a   Dong, Jin Tang ^b   Isaacs, John T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 11P; GENE EXPRESSION; HUMAN; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIGENS, CD44; CHROMOSOMES; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HUMANS; MALE; NEOPLASM METASTASIS; PROSTATE; PROSTATIC NEOPLASMS; RATS; TUMOR CELLS, CULTURED;

EID: 0031019095     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ichikawa, Y., Dong, J. T., Hawkins, A. L., Griffin, C. A., Isaacs, W. B., Oshimura, M., Barrett, C. J., and Isaacs, J. T. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res., 52: 3486-3490, 1992.
2. Ichikawa, T., Nihei, N., Suzuki, H., Mitsuo, O., Mitsuru, E., Nakamura, Y., Hayata, I., Isaacs, J. T., and Shimazaki, J. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res., 54: 2299-2302, 1994.
3. Nihei, N., Ichikawa, T., Kawana, Y., Kuramochi, H., Kugo, H., Oshimura, M., Killary, A. M., Rinker-Schaeffer, C. W., Barren, J. C., Isaacs, J. T., and Shimazaki, J. Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosomes & Cancer, 14: 112-119, 1995.
4. Rinker-Schaeffer, C. W., Hawkins, A. L., Ru, N., Dong, J. T., Stoice, G., Griffin, C., Ichikawa, T., Barren, J. C., and Isaacs, J. T. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Cancer Res., 54: 6249-6256, 1994.
5. Dong, J. T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barren, J. C. KAIL a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science (Washington DC), 268: 884-886, 1995.
6. Gunthert, U., Stauder, R., Mayer, B., Terpe, H., Finke, L., and Friedrichs, K. Are CD44 variant isoforms involved in human tumor progression? Cancer Surv., 24: 19-42, 1995.
7. Goldstein, L. A., Zhou, D. F., Picker, L. J., Minty, C. N., Bargatze, R. F., Ding, J. F., and Butcher, E. C. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell, 56: 1063-1072, 1989.
8. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornells, F. B., Gerth, U., and Bell, J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA, 89: 12160-12164, 1992.
9. Screaton, G. R., Bell, M. V., Bell, J. I., and Jackson, D. G. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor: comparison of all 10 variable exons between mouse, human, and rat. J. Biol. Chem., 265: 12235-12238, 1993.
10. Underhill, C. CD44: the hyaluronan receptor, J. Cell Sci., 103: 293-298, 1992.
11. Weber, G. F., Ashkar, S., Glimcher, M. J., and Cantor, H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science (Washington DC), 271: 509-512, 1996.
12. Gumhert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haubmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
13. Rudy, W., Hofmann, M., Schwartz-Albiez, R., Zoller, M., Heider, K., Ponta, H., and Herrlich, P. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res., 53: 1262-1268, 1993.
14. Sy, M. S., Guo, Y. J., and Stamenkovic, I. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med., 174: 859-866, 1991.
15. Salmi, M., Virta, G. P., Sointu, P., Grenman, R., Kalimao, H., and Jalkanen, S. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin, J. Cell Biol., 122: 431-442, 1993,
16. Tanabe, K. K., Stamenkovic, I., Culter, B. S., and Takahashi, K. Restoration of CD44H expression in colon carcinoma reduces tumorigenicity. Ann. Surg., 222: 493-503, 1995.
17. Isaacs, J. T., Isaacs, W. B., Feitz, W. F. J., and Scheres, J. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate, 9: 261-281, 1986.
18. Isaacs, J. T., and Hukku, B. Nonrandom involvement of chromosome 4 in the progression of rat prostatic cancer. Prostate. 13: 165-188, 1988.
19. Kallakury, B. V. S., Yang, F., Figge, J., Smith, K., Kausik, S. J., Tacy, N. J., Fisher, H. A. G., Kaufman, R., Figge, H., and Ross, J. S. Decreased levels of CD44 protein and mRNA in prostate carcinoma: correlation with tumor grade and ploidy. Cancer (Phila.), 78: 1461-1469, 1996.
20. Dong, J., Suzuki, H. S., Pin, S. S., Bova, S., Schalken, J. A., Isaacs, W. B., Barrett, J. C., and Isaacs, J. T. Down-regulation of the KAI 1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res., 56: 4387-4390, 1996.